Funds and ETFs Baxter International Inc.

Equities

BAX

US0718131099

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:01 2024-06-07 pm EDT 5-day change 1st Jan Change
33.16 USD -0.48% Intraday chart for Baxter International Inc. -2.73% -14.23%

ETFs positioned on Baxter International Inc.

Name Weight AuM 1st Jan change Investor Rating
13.07% 208 M€ +13.89% -
1.23% 21 M€ +7.83% -
0.81% 4 M€ +20.15%
0.75% 7 M€ +5.53%
0.73% 2 M€ +9.08%
0.40% 9 M€ -.--% -
0.38% 1 M€ +2.21% -
0.24% 5 M€ -72.95% -
0.19% 2,334 M€ +16.24%
0.19% 7 M€ +0.11% -
0.16% 10 M€ +10.28%
0.15% 9 M€ +7.98% -
0.15% 825 M€ +10.15%
0.14% 4 M€ -.--% -
0.13% 261 M€ -.--% -
0.13% 200 M€ +11.72% -
0.13% 488 M€ +14.46%
0.13% 1,448 M€ -.--% -
0.13% 219 M€ +17.17% -
0.12% 330 M€ -.--% -
0.11% 252 M€ +7.82%
0.11% 26 M€ +23.55% -
0.10% 26 M€ +16.85% -
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
33.16 USD
Average target price
45.44 USD
Spread / Average Target
+37.03%
Consensus
  1. Stock Market
  2. Equities
  3. BAX Stock
  4. Funds and ETFs Baxter International Inc.